Gemcitabine liposomal suspension (FUJIFILM Corp)

吉西他滨脂质体（FUJIFILM Corp）

Report date: 2025/07/15 11:53:20

Base Information

Drug NameGemcitabine liposomal suspension (FUJIFILM Corp)
Drug Alias NameFF-10832 (吉西他滨脂质体)FF-10832
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionDNA inhibitorsRNA inhibitors
TargetsDNARibonucleic Acid
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungBiliary Tract Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesFujifilm Corp
China Registration ClassN/A

Develop Information

Active CompaniesFujifilm Pharmaceuticals U.S.A. Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungBiliary Tract Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A